GBR-12,935
GBR-12935 is a psychoactive drug and research chemical widely used in scientific studies. It acts primarily as a potent and selective dopamine reuptake inhibitor, with a particular focus on the dopamine transporter (DAT). GBR-12935 has been instrumental in the study of dopamine system disorders, such as Parkinson's disease, schizophrenia, and drug addiction.
Chemistry[edit | edit source]
GBR-12935 belongs to the phenyltropane class of compounds, which are known for their stimulant and anorectic properties. Its chemical structure is similar to that of cocaine, although its pharmacological profile is significantly different, primarily due to its selectivity for the dopamine transporter.
Pharmacology[edit | edit source]
The primary mechanism of action of GBR-12935 is the inhibition of dopamine reuptake. By binding to the dopamine transporter, GBR-12935 prevents the reabsorption of dopamine into the presynaptic neuron, leading to an increase in dopamine levels in the synaptic cleft. This increase in extracellular dopamine concentrations can significantly affect mood, motivation, and movement, which is why GBR-12935 is of particular interest in the study of dopamine-related disorders.
Research Uses[edit | edit source]
GBR-12935 has been extensively used in research to understand the role of the dopamine transporter in various neurological and psychiatric conditions. It has also been used as a tool to investigate the effects of increased synaptic dopamine levels. Due to its high selectivity for the dopamine transporter, GBR-12935 is a valuable compound in the development of potential therapeutic agents for the treatment of conditions such as depression, Parkinson's disease, and drug addiction.
Legal Status[edit | edit source]
The legal status of GBR-12935 varies by country, but it is primarily considered a research chemical and is not approved for medical use or recreational consumption. Its possession and distribution are regulated in many jurisdictions due to its psychoactive properties and potential for abuse.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
